Javascript must be enabled to continue!
Recent trends in rifamycin research
View through CrossRef
AbstractRifamycin is a clinically useful macrolide antibiotic produced by the gram positive bacterium. Amycolatopsis mediterranei. This antibiotic is primarily used against Mycobacterium tuberculosis and Mycobacterium leprae, causative agents of tuberculosis and leprosy, respectively. In these bacteria, rifamycin treatment specifically inhibits the initiation of RNA synthesis by binding to β‐subunit of RNA polymerase. Apart from its activity against the bacteria, rifamycin has also been reported to inhibit reverse transcriptase (RT) of certain RNA viruses. Recently, rifamycin derivatives have been dis‐covered that are effective against Mycobacterium avium, which is associated with the AIDS complex. Consequently, the importance of and demand for rifamycin has increased tremendously, the world over. In this article, recent trends in rifamycin research and accessability of recombinant DNA techniques to increase rifamycin production are reviewed.
Title: Recent trends in rifamycin research
Description:
AbstractRifamycin is a clinically useful macrolide antibiotic produced by the gram positive bacterium.
Amycolatopsis mediterranei.
This antibiotic is primarily used against Mycobacterium tuberculosis and Mycobacterium leprae, causative agents of tuberculosis and leprosy, respectively.
In these bacteria, rifamycin treatment specifically inhibits the initiation of RNA synthesis by binding to β‐subunit of RNA polymerase.
Apart from its activity against the bacteria, rifamycin has also been reported to inhibit reverse transcriptase (RT) of certain RNA viruses.
Recently, rifamycin derivatives have been dis‐covered that are effective against Mycobacterium avium, which is associated with the AIDS complex.
Consequently, the importance of and demand for rifamycin has increased tremendously, the world over.
In this article, recent trends in rifamycin research and accessability of recombinant DNA techniques to increase rifamycin production are reviewed.
Related Results
A STUDY ON THE USE OF DIFFERENT MATERIALS COMBINED WITH ALLOGRAFT ON OSSEOINTEGRATION AND BONE REGENERATION OF DENTAL IMPLANTS WITH CORONAL DEFECTS IN A RABBIT MODEL
A STUDY ON THE USE OF DIFFERENT MATERIALS COMBINED WITH ALLOGRAFT ON OSSEOINTEGRATION AND BONE REGENERATION OF DENTAL IMPLANTS WITH CORONAL DEFECTS IN A RABBIT MODEL
Objectives: To assess differential effects of different materials combined with allograft on bone-to-implant contact and newly formed bone formation in dental implants with coronal...
Pharmacokinetics and Safety of Rifamycin SV after Single and Multiple Doses of MMX® Modified Release Tablets in Healthy Male and Female Volunteers
Pharmacokinetics and Safety of Rifamycin SV after Single and Multiple Doses of MMX® Modified Release Tablets in Healthy Male and Female Volunteers
The primary objective of this single- and multiple-dose pharmacokinetic study was the investigation of rifamycin SV’s pharmacokinetic profile in plasma and urine. All the 18 enroll...
Systemic Absorption of Rifamycin SV MMX Administered as Modified-Release Tablets in Healthy Volunteers
Systemic Absorption of Rifamycin SV MMX Administered as Modified-Release Tablets in Healthy Volunteers
ABSTRACT
The new oral 200-mg rifamycin SV MMX modified-release tablets, designed to deliver rifamycin SV directly into the colonic lumen, offer considerable advantages ov...
Genome Mining Reveals Rifamycin Biosynthesis in a Taklamakan Desert Actinomycete
Genome Mining Reveals Rifamycin Biosynthesis in a Taklamakan Desert Actinomycete
Actinomycetes are recognized for producing diverse bioactive natural products, yet most biosynthetic gene clusters (BGCs) remain inactive under laboratory conditions. Rare actinomy...
In Vitro Preliminary Evaluation of a New Rifamycin In Situ Gelling Formulation for Pouchitis Treatment
In Vitro Preliminary Evaluation of a New Rifamycin In Situ Gelling Formulation for Pouchitis Treatment
Pouchitis is one of the most common long-term complications after ileal pouch–anal anastomosis (IPAA) surgery, with a reported incidence rate of up to 50%. Identifying specific bac...
Whole Genome Sequence of the Rifamycin B-Producing Strain Amycolatopsis mediterranei S699
Whole Genome Sequence of the Rifamycin B-Producing Strain Amycolatopsis mediterranei S699
ABSTRACT
Amycolatopsis mediterranei
S699 is an actinomycete that produces an important antibiotic, rifamycin B. Semisynthetic derivatives of rifa...
The Role of Internal Variability in Seasonal Hindcast Trend Errors
The Role of Internal Variability in Seasonal Hindcast Trend Errors
Abstract
Initialized hindcasts inherit knowledge of the observed climate state, so studies of multidecadal trends in seasonal and decadal hindcast models have focused on the ensemb...
A macroevolution-inspired approach to reveal novel antibiotic resistance mechanisms
A macroevolution-inspired approach to reveal novel antibiotic resistance mechanisms
With the continuous rise in antibiotic resistance, novel methods that can reveal currently unknown antibiotic resistance mechanisms are essential to prepare and inform health respo...

